FDA Warning Letter — Konrad Rejdak, M.D.
The FDA took a Warning Letter action against Konrad Rejdak, M.D. on May 29, 2024 (Lublin, Poland). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Konrad Rejdak, M.D.
- Date
- May 29, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Center
- CBER
- Location
- Lublin (Poland)